NKGen Biotech, Inc. Common Stock
NKGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $18,890 | $42,424 | $122,490 | $122,490 |
| - Cash | $0 | $26 | $117 | $351 |
| + Debt | $0 | $19,921 | $12,034 | $51,971 |
| Enterprise Value | $18,890 | $62,319 | $134,407 | $174,110 |
| Revenue | $0 | $0 | $77 | $426 |
| % Growth | – | -100% | -81.9% | – |
| Gross Profit | $0 | -$1,203 | $59 | $396 |
| % Margin | – | – | 76.6% | 93% |
| EBITDA | -$26,966 | -$80,999 | -$23,231 | -$20,701 |
| % Margin | – | – | -30,170.1% | -4,859.4% |
| Net Income | -$44,286 | -$82,954 | -$26,754 | -$23,265 |
| % Margin | – | – | -34,745.5% | -5,461.3% |
| EPS Diluted | -1.54 | -5.38 | -1.25 | -1.08 |
| % Growth | 71.4% | -330.4% | -15.7% | – |
| Operating Cash Flow | -$20,881 | -$21,948 | -$22,557 | -$19,548 |
| Capital Expenditures | $0 | -$48 | -$163 | -$459 |
| Free Cash Flow | -$20,881 | -$21,996 | -$22,720 | -$20,007 |